Akebia Therapeutics Inc. (NASDAQ: AKBA) started the day on Wednesday, remained unchanged at $1.37, before settling in for the price of $1.37 at the close.
Akebia Therapeutics Inc. (NASDAQ: AKBA) kicked off on Friday, down -2.16% from the previous trading day, before settling in for the closing price of $1.39.
Akebia Therapeutics Inc. (NASDAQ: AKBA) flaunted slowness of -0.71% at $1.39, before settling in for the price of $1.40 at the close. Taking a more
On Friday, Akebia Therapeutics Inc. (NASDAQ: AKBA) opened lower -4.58% from the last session, before settling in for the closing price of $1.53. Price fluctuations
Akebia Therapeutics Inc. (NASDAQ: AKBA) established initial surge of 1.30% at $1.56, before settling in for the price of $1.54 at the close. Taking a
On Friday, Akebia Therapeutics Inc. (NASDAQ: AKBA) opened lower -1.32% from the last session, before settling in for the closing price of $1.51. Price fluctuations
Akebia Therapeutics Inc. (NASDAQ: AKBA) flaunted slowness of -5.70% at $1.49, before settling in for the price of $1.58 at the close. Taking a more
Akebia Therapeutics Inc. (NASDAQ: AKBA) kicked off on Thursday, down -18.30% from the previous trading day, before settling in for the closing price of $2.24.
Witnessing the stock’s movement on the chart, on May 24, 2023, Akebia Therapeutics Inc. (NASDAQ: AKBA) set off with pace as it heaved 2.88% to
May 19, 2023, Akebia Therapeutics Inc. (NASDAQ: AKBA) trading session started at the price of $1.08, that was 6.42% jump from the session before. During
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
